Navigation Links
Abbott Releases 2007 Global Citizenship Report Highlighting Strong Commitment to Access to Health Care
Date:6/2/2008

Company's Report Entitled, 'Ingenuity at Work,' Discusses Abbott's Contributions to Access, Innovation, Science Education and the Environment

ABBOTT PARK, Ill., June 2 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) today released its 2007 Global Citizenship Report, "Ingenuity at Work," which is available online at http://www.abbott.com/citizenship. The report highlights Abbott's commitment to access to care, innovation, science education and the environment.

Named to the Dow Jones Sustainability World and North American Indices in 2007 for the third consecutive year, Abbott remains a leader in economic, social and environmental performance -- with the company and the Abbott Fund contributing more than $385 million in grants and products to help improve the lives of millions of people around the world.

"To us, citizenship challenges are core business challenges -- they're part of how we effectively develop, manufacture and market a product," said Miles D. White, chairman and chief executive officer, Abbott. "We view citizenship as a matter of competitiveness and business discipline. We find it invigorating that society is demanding more of business enterprises today, and we're energized to meet and extend these new standards."
Following are some of Abbott's major accomplishments in 2007:

Access to Care

-- Provided support and resources to clinics and laboratories in Africa to

help people in need access medical care and supplies. Abbott plans to

help modernize 23 additional laboratories in Africa in 2010.

-- Offered more than $183 million worth of free Abbott medicines,

nutritionals and medical devices through patient assistance programs

worldwide.

Innovation

-- Invested more than $2.5 billion in research and development, an

increase of 11.1 percent from the previous year. Through medical

advancements and new scientific technologies, Abbott is tackling some

of today's most pressing chronic diseases -- diabetes, cancer and

cardiovascular disease.

-- Introduced the first and only co-formulated protease inhibitor tablet

suitable for children with HIV. The tablet does not require

refrigeration and does not need to be taken with food -- two important

advances in delivering HIV medicine. Kaletra (known as Aluvia in

developing countries) was filed or has been approved in 156 developed

and developing countries.

Science Education

-- Supported science education in the United States through a new program

called "Labs Are Vital," which helps to raise awareness of the

life-saving work clinical laboratory professionals provide in improving

health outcomes.

-- Launched pilot programs to enhance science education and worked closely

with teachers in several U.S. cities to promote science in the

classrooms. In 2008, Abbott aims to expand these programs across the

country.

Environment

-- Became the first FORTUNE 500 company to go "carbon neutral" with its

fleet of sales vehicles.

-- Improved operations to help protect the environment, including reducing

carbon dioxide (CO2) emissions with plans to reduce total emissions by

30 percent by 2011.

-- Continued to work towards 2010 goals to reduce water usage, waste,

employee injuries and commercial vehicle fleet accidents to help

generate the greatest environmental, health and safety benefits.

About Abbott's 2007 Global Citizenship Report

Abbott's full 2007 report is now available online at http://www.abbott.com/citizenship, including a copy of the company's Global Reporting Initiative (GRI) Index. In order to reduce its environmental impact, the company published a shortened version of the print report and expanded the information available on its Web site. The abbreviated print version can be downloaded from the Web site or requested by email at globalcitizenship@abbott.com.

About Abbott

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs more than 68,000 people and markets its products in more than 130 countries. Abbott's news releases and other information are available on the company's Web site at http://www.abbott.com.


'/>"/>
SOURCE Abbott
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Abbott to Present at Bear Stearns Healthcare Conference
2. The National Center for Missing & Exploited Children, Wal-Mart, and Abbott Host Child Safety Events
3. Dow Jones Sustainability Index Again Recognizes Abbott for Continued Leadership in Business, Environmental and Social Performance
4. Abbott Declares 335th Consecutive Quarterly Dividend
5. Abbott Again Honored as Top Company for Working Moms
6. Abbotts HUMIRA(R) (adalimumab) Honored With Prestigious Galen Prize for Innovation in Patient Care
7. Abbott Hosts Conference Call for Third-Quarter Earnings
8. Abbott Broadens Use of i-STAT Handheld Blood Analyzer with CLIA Waiver Granted by FDA for CHEM8+ Test Cartridge
9. Abbott Named One of the Best Companies for Hispanics by Hispanic Business Magazine
10. Abbott Again Honored as a Leader in Diversity
11. Abbott Researchers Target Neuronal Nicotinic Receptors for Treatment of Pain and Cognition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... February 23, 2017 , ... Top cosmetic and periodontal ... program today with a new Indiegogo campaign . Individuals are now able ... in the Los Angeles area, either as a participating patient or through an Indiegogo ...
(Date:2/23/2017)... ... 2017 , ... Thomas Vas-Don suffered from severe injury due to ... able to successfully recover. In “ Origin & Insertion Charts for Massage Therapists ” ... principals of massage, anatomy , trigger points and referral pain patterns . ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... It’s enough to overwork even the sharpest brain. , Power On, a mental ... activity without over clocking the brain. Each capsule contains Cognizin® Citicoline, a branded ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... The ... to the thousands of individuals who have recently fallen victim to America’s opioid epidemic. ... in Orange County, California, where they are free from the shame, stigma, and ...
(Date:2/22/2017)... Northbrook, IL (PRWEB) , ... February 22, 2017 , ... ... stories, is proud to once again feature Heroes On The Water (HOW), a non-profit ... This season’s all new episode has series host ‘Mike D’ traveling to Lake Denmark, ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... , Feb. 23, 2017 Regulus Therapeutics ... discovery and development of innovative medicines targeting microRNAs, today ... 2016 financial results on Thursday, March 2, 2017 after ... conference call and webcast on March 2, 2017 at ... full year 2016 financial results and provide a general ...
(Date:2/23/2017)... The fast-growing cannabis market is expected to create ... According to the 2017 Legal Marijuana Outlook, published by New ... jobs by 2020, with an implied growth rate of more ... accelerating pace of cannabis legalization is considered as the main ... will further create more business ventures and boost the economy. ...
(Date:2/23/2017)... South Korea , Feb. 23, 2017 LG Innotek ... UV-C LED for sterilization applications. As its sterilization performance is 1.5 ... produces the short wavelength ultraviolet rays in the range of 200 -- ... the proliferation of bacteria by destroying their DNA. LG Innotek,s product ... ...
Breaking Medicine Technology: